Planor

Planor may be available in the countries listed below.

Ingredient matches for Planor

Clopidogrel

Clopidogrel is reported as an ingredient of Planor in the following countries:

• Turkey

International Drug Name Search

Fluoxetina Alpharma

Fluoxetina Alpharma may be available in the countries listed below.

Ingredient matches for Fluoxetina Alpharma

Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Alpharma in the following countries:

• Portugal

International Drug Name Search

Norsec

Norsec may be available in the countries listed below.

Ingredient matches for Norsec

Omeprazole

Omeprazole is reported as an ingredient of Norsec in the following countries:

• Indonesia

International Drug Name Search

Refen

Refen may be available in the countries listed below.

Ingredient matches for Refen

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Refen in the following countries:

• Romania

International Drug Name Search

Stoppot

Stoppot may be available in the countries listed below.

Ingredient matches for Stoppot

Methenamine

Methenamine is reported as an ingredient of Stoppot in the following countries:

• Poland

International Drug Name Search

Roxigamma

Roxigamma may be available in the countries listed below.

Ingredient matches for Roxigamma

Roxithromycin

Roxithromycin is reported as an ingredient of Roxigamma in the following countries:

• Germany

International Drug Name Search

diphtheria and tetanus vaccine Intramuscular

dif-THEER-ee-a TOX-oyd, ad-SORBD, TET-n-us TOX-oyd

Commonly used brand name(s)

In the U.S.

• Decavac

Available Dosage Forms:

• Suspension

Therapeutic Class: Vaccine

Uses For diphtheria and tetanus vaccine

Diphtheria and tetanus vaccine is a combination vaccine that is given to protect against infections caused by diphtheria and tetanus (lockjaw). The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given to children 6 weeks of age and older, teenagers, and adults.

Diphtheria is a serious illness that can cause breathing problems, heart problems, nerve damage, pneumonia, and possibly death. The risk for serious illness is greater in very young children and the elderly.

Tetanus (also known as lockjaw) is a very serious illness that causes severe muscle spasms that make the muscles very rigid or stiff. The muscle spasms can be strong enough to cause bone fractures in the spine. The disease can also cause breathing problems, swallowing problems, seizures, and possibly death.

This vaccine is to be administered only by or under the direct supervision of a doctor.

Before Using diphtheria and tetanus vaccine

In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to diphtheria and tetanus vaccine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of Diphtheria and Tetanus Toxoids Vaccine for Pediatric Use in children 7 years of age and older. Safety and efficacy have not been established.

Appropriate studies have not been performed on the relationship of age to the effects of Decavac® vaccine in children younger than 7 years of age. Safety and efficacy have not been established.

Geriatric

Although appropriate studies on the relationship of age to the effects of Decavac® vaccine have not been performed in the geriatric population, no geriatric-specific problems have been documented to date.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:

• Allergic reaction to a tetanus vaccine (eg, Arthus-type reaction) or


• Guillain-Barré syndrome (nerve disease that causes paralysis) after a tetanus vaccine, history of—Your doctor will decide if you should receive this vaccine.

• Immunodeficiency disorder (low blood counts for white cells or platelets) or


• Weakened immune system—May not work as well in patients with these conditions.

Proper Use of diphtheria and tetanus vaccine

A nurse or other trained health professional will give you or your child this vaccine. This vaccine is given as a shot into one of your muscles, usually in the upper leg for infants or in the shoulder for older children, teenagers, and adults.

Depending on the age of the child, this vaccine is given as a series of 3 or 4 doses. Teenagers and adults will receive a total of 3 doses.

After the first set of shots, you or your child should get a booster shot every 10 years.

It is important that you or your child receive all of the doses of vaccine in this series. Try to keep all of your scheduled appointments. If you miss a dose, make another appointment as soon as possible.

Precautions While Using diphtheria and tetanus vaccine

It is very important that you or your child return to your doctor’s office at the right time for the next dose. Be sure to notify your doctor of any unwanted effects that occur after you receive the vaccine.

If you or your child develop a skin rash, hives, or any allergic reaction after receiving this vaccine, tell your doctor right away.

Tell your doctor right away if you or your child are allergic to latex rubber. The prefilled syringes or bottle of vaccine may contain natural rubber latex. This may cause an allergic reaction in patients who are sensitive to latex.

This vaccine will not treat an active infection. If you or your child have an infection due to diphtheria or tetanus, you will need medicine to treat the infection.

diphtheria and tetanus vaccine Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

Less common

• Fever


• general feeling of discomfort or illness


• unusual tiredness or weakness

Incidence not known

• Bloating or swelling of the face, arms, hands, lower legs, or feet


• burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings


• chills


• convulsions


• cough


• difficulty with swallowing


• dizziness


• fainting


• fast heartbeat


• hives


• itching


• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue


• rapid weight gain


• shortness of breath


• skin rash


• swelling or puffiness of the face


• swollen, painful, or tender lymph glands in the neck, armpit, or groin


• tightness in the chest


• tingling of the hands or feet


• unusual weight gain or loss


• wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Hard lumps, redness, tenderness, or warmth at the injection site

Less common

• Headache

Incidence not known

• Difficulty with moving


• joint pain


• lack or loss of strength


• muscle aching or cramping


• muscle stiffness


• nausea


• pain in the arms or legs


• swollen joints


• vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More diphtheria and tetanus vaccine Intramuscular resources

• Diphtheria and tetanus vaccine Intramuscular Use in Pregnancy & Breastfeeding
• Diphtheria and tetanus vaccine Intramuscular Drug Interactions
• Diphtheria and tetanus vaccine Intramuscular Support Group
• 0 Reviews for Diphtheria and tetanus vaccine Intramuscular - Add your own review/rating

Compare diphtheria and tetanus vaccine Intramuscular with other medications

• Diphtheria Prophylaxis
• Tetanus Prophylaxis

Hospira Piperacillin / Tazobactam

Hospira Piperacillin/ Tazobactam may be available in the countries listed below.

Ingredient matches for Hospira Piperacillin/ Tazobactam

Piperacillin

Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Hospira Piperacillin/ Tazobactam in the following countries:

• Ireland

Tazobactam

Tazobactam sodium salt (a derivative of Tazobactam) is reported as an ingredient of Hospira Piperacillin/ Tazobactam in the following countries:

• Ireland

International Drug Name Search

Epididymitis Medications

Definition of Epididymitis: Epididymitis is swelling (inflammation) of the epididymis, the tube that connects the testicle with the vas deferens.

Topics under Epididymitis

• Epididymitis, Non-Specific (4 drugs)

• Epididymitis, Sexually Transmitted (18 drugs)

Learn more about Epididymitis

Medical Encyclopedia:

• Epididymitis

Drug List:

Clonazepam

In the US, Clonazepam (clonazepam systemic) is a member of the following drug classes: benzodiazepine anticonvulsants, benzodiazepines and is used to treat Anxiety, Benzodiazepine Withdrawal, Bipolar Disorder, Burning Mouth Syndrome, Insomnia, Migraine Prevention, Night Terrors, Panic Disorder, Periodic Limb Movement Disorder, Restless Legs Syndrome and Seizure Prevention.

US matches:

• Clonazepam


• Clonazepam Orally Disintegrating Tablets


• Clonazepam Tablet Orally Disintegrating

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AE01

CAS registry number (Chemical Abstracts Service)

0001622-61-3

Chemical Formula

C15-H10-Cl-N3-O3

Molecular Weight

315

Therapeutic Category

Antiepileptic agent

Chemical Name

2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-

Foreign Names

• Clonazepamum (Latin)
• Clonazepam (German)
• Clonazépam (French)
• Clonazepam (Spanish)

Generic Names

• Clonazepam (OS: BAN, JAN, DCIT, USAN)
• Clonazépam (OS: DCF)
• B-7 (IS)
• Ro 5-4023 (IS)
• Clonazepam (PH: BP 2010, JP XV, USP 32, Ph. Eur. 6)
• Clonazépam (PH: Ph. Eur. 6)
• Clonazepamum (PH: Ph. Eur. 6)

Brand Names

• Acepran
  ABL, Peru; Andromaco, Chile



• Aklonil
  Medochemie, Tunisia



• Alerion
  Filaxis, Argentina



• Antelepsin
  Asta Medica, Czech Republic; AWD.pharma, Lithuania; Desitin, Georgia



• Anzatax
  Carrion, Peru



• Apo-Clonazepam
  Apotex, Canada; Apotex, Guyana



• Arotril
  Aristopharma, Bangladesh



• Celaxin
  Pharmavita, Chile



• Ciclox
  Sandoz, Argentina



• Clobenzepam
  Benham, Bangladesh



• Clon
  Globe, Bangladesh



• Clonabay
  Bayer, Argentina



• Clonagin
  Baliarda, Argentina



• Clonapam
  Chile, Chile; Medco, Peru



• Clonapilep
  Bruluart, Mexico



• Clonatril GMP
  Giempi, Venezuela



• Clonax
  Beta, Argentina



• Clonazepam Dosa
  Dosa, Argentina



• Clonazepam Duncan
  Duncan, Argentina



• Clonazepam Monte Verde
  Monte, Argentina



• Clonazepam Northia
  Northia, Argentina



• Clonazepam Sine Pharm
  Sine Pharm, China



• Clonazepam
  AC Farma, Peru; Actavis, United States; Alphapharm, United States; Caraco, United States; Farmindustria, Peru; Infarmasa, Peru; Iqfarma, Peru; Kali, United States; LCG, Peru; Mintlab, Chile; Mylan, United States; Olainfarm, Latvia; Polfa Tarchomin, Georgia; Polfa Tarchomin, Lithuania; Polfa Tarchomin, Russian Federation; Polfa Tarchomin S. A., Hungary; Sandoz, United States; Teva USA, United States; Torpharm, United States; Vintage, United States; Watson, United States



• Clonazepamum
  Polfa Tarchomin, Poland



• Cloner
  Vannier, Argentina



• Clonex
  Teva, Israel



• Clonotril
  Torrent, Brazil



• Cloron
  Eskayef, Bangladesh



• Clozanil
  Sanitas, Chile



• Clozer
  Sun Pharma, Mexico



• CO Clonazepam
  Cobalt, Canada



• Colonopam
  Synpac, Taiwan



• Coquan
  Psipharma, Colombia



• Diocam
  Elisium, Argentina



• Disopan
  Incepta, Bangladesh



• Edictum
  Phoenix, Argentina



• Epiclon
  General Pharma, Bangladesh



• Epitra
  Square, Bangladesh



• Epitril
  Novartis, India



• Epnil
  Novartis, Bangladesh



• Esypan
  Silva, Bangladesh



• Flozepan
  Lazar, Argentina



• Gen-Clonazepam
  Genpharm, Canada



• Iktorivil
  Roche, Sweden



• Induzepam
  Finadiet, Argentina



• Kenoket
  Kendrick, Mexico



• Klonopin
  Roche, United States



• Kriadex
  Psicofarma, Mexico



• Landsen
  Dainippon Sumitomo, Japan



• Leptic
  Acme, Bangladesh; Soubeiran Chobet, Argentina



• Lonazep
  Sun, Bangladesh; Sun, India



• Neuryl
  Bago, Chile; Bagó, Argentina; Bagó, Ecuador



• Olimer
  Rontag, Argentina



• Pase
  Opsonin, Bangladesh



• Paxam
  Alphapharm, Australia; Pacific, New Zealand



• PMS-Clonazepam
  Pharmascience, Canada; Pharmascience, Tunisia



• ratio-Clonazepam
  ratiopharm, Canada



• Ravotril
  Roche, Chile



• Riklona 2
  Mersifarma, Indonesia



• Riuclonaz
  Medipharma, Argentina



• Rivatril
  Roche, Finland



• Rivotril Roche
  Roche, Austria



• Rivotril
  Chugai, Japan; Euro, Netherlands; Galenika, Serbia; Roche, United Arab Emirates; Roche, Albania; Roche, Argentina; Roche, Australia; Roche, Aruba; Roche, Azerbaijan; Roche, Bosnia & Herzegowina; Roche, Bangladesh; Roche, Belgium; Roche, Bulgaria; Roche, Bahrain; Roche, Benin; Roche, Bolivia; Roche, Brazil; Roche, Canada; Roche, Congo; Roche, Switzerland; Roche, Cote D'ivoire; Roche, Chile; Roche, Colombia; Roche, Cuba; Roche, Cyprus; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Dominican Republic; Roche, Algeria; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Ethiopia; Roche, Finland; Roche, France; Roche, United Kingdom; Roche, Georgia; Roche, Ghana; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Israel; Roche, Iraq; Roche, Iceland; Roche, Italy; Roche, Jamaica; Roche, Jordan; Roche, Kenya; Roche, South Korea; Roche, Kuwait; Roche, Kazakhstan; Roche, Laos; Roche, Lebanon; Roche, Sri Lanka; Roche, Lithuania; Roche, Luxembourg; Roche, Morocco; Roche, Malta; Roche, Mauritius; Roche, Mexico; Roche, Malaysia; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Pakistan; Roche, Portugal; Roche, Paraguay; Roche, Qatar; Roche, Serbia; Roche, Russian Federation; Roche, Saudi Arabia; Roche, Singapore; Roche, Slovenia; Roche, Slovakia; Roche, Senegal; Roche, Thailand; Roche, Turkmenistan; Roche, Turkey; Roche, Trinidad & Tobago; Roche, Taiwan; Roche, Tanzania; Roche, Uganda; Roche, Uruguay; Roche, Uzbekistan; Roche, Venezuela; Roche, South Africa; Roche, Zambia; Roche, Zimbabwe



• Ropsil
  Medipharm, Chile



• Sandoz Clonazepam
  Sandoz, Canada



• Sedatril
  Tecnoquimicas, Colombia



• Sedovanon
  Craveri, Argentina



• Sensaton
  Temis-Lostalo, Argentina



• Solfidin
  Rontag, Argentina



• Valpax
  Drugtech-Recalcine, Chile; Recalcine, Ecuador



• Xetril
  Beximco, Bangladesh



• Zatrix
  Farmindustria, Peru



• Zymanta
  Asofarma, Mexico

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Detoxicol

Detoxicol may be available in the countries listed below.

Ingredient matches for Detoxicol

Lactulose

Lactulose is reported as an ingredient of Detoxicol in the following countries:

• Sri Lanka

International Drug Name Search

Carbocisteina DOC

Carbocisteina DOC may be available in the countries listed below.

Ingredient matches for Carbocisteina DOC

Carbocisteine

Carbocisteine is reported as an ingredient of Carbocisteina DOC in the following countries:

• Italy

International Drug Name Search

Trivora

In the US, Trivora (ethinyl estradiol/levonorgestrel systemic) is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Endometriosis, Gonadotropin Inhibition, Ovarian Cysts and Polycystic Ovary Syndrome.

US matches:

• Trivora


• Trivora-28

Ingredient matches for Trivora

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Trivora in the following countries:

• United States

Levonorgestrel

Levonorgestrel is reported as an ingredient of Trivora in the following countries:

• United States

International Drug Name Search

Enoxaparin Sodium

Enoxaparin Sodium may be available in the countries listed below.

Ingredient matches for Enoxaparin Sodium

Enoxaparin

Enoxaparin Sodium (BAN, USAN) is known as Enoxaparin in the US.

International Drug Name Search

Glossary

BAN	British Approved Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Vencoll

Vencoll may be available in the countries listed below.

Ingredient matches for Vencoll

Casanthranol

Casanthranol is reported as an ingredient of Vencoll in the following countries:

• Japan

Dioctyl Sulfosuccinic Acid

Dioctyl Sulfosuccinic Acid sodium salt (a derivative of Dioctyl Sulfosuccinic Acid) is reported as an ingredient of Vencoll in the following countries:

• Japan

International Drug Name Search

Omeprazole Delayed-Release Capsules

Pronunciation: oh-MEP-ra-zole
Generic Name: Omeprazole
Brand Name: Prilosec

Omeprazole Delayed-Release Capsules are used for:

Treating heartburn or irritation of the esophagus caused by gastroesophageal reflux disease (GERD). It may also be used for short-term treatment of ulcers of the stomach or small intestine. It may also be used with certain antibiotics to treat ulcers of the small intestines and to help prevent them from coming back. It may also be used to treat conditions that cause your body to make too much stomach acid (eg, Zollinger-Ellison syndrome). It may also be used for other conditions as determined by your doctor.

Omeprazole Delayed-Release Capsules are a proton pump inhibitor (PPI). It works by decreasing the amount of acid produced in the stomach.

Do NOT use Omeprazole Delayed-Release Capsules if:

• you are allergic to any ingredient in Omeprazole Delayed-Release Capsules


• you are taking dasatinib, certain HIV protease inhibitors (eg, atazanavir, nelfinavir), rifampin, or St. John's wort.

Contact your doctor or health care provider right away if any of these apply to you.

Before using Omeprazole Delayed-Release Capsules:

Some medical conditions may interact with Omeprazole Delayed-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have low blood potassium or magnesium levels, liver problems, or stomach or bowel cancer


• if you have osteoporosis (weak bones), a family history of osteoporosis, or other risk factors of osteoporosis (eg, smoking, poor nutrition)

Some MEDICINES MAY INTERACT with Omeprazole Delayed-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Diuretics (eg, furosemide, hydrochlorothiazide) because the risk of low blood magnesium levels may be increased


• Voriconazole because it may increase the risk of Omeprazole Delayed-Release Capsules's side effects


• Ginkgo biloba, rifampin, or St. John's wort because they may decrease Omeprazole Delayed-Release Capsules's effectiveness


• Anticoagulants (eg, warfarin), benzodiazepines (eg, diazepam), cilostazol, cyclosporine, digoxin, disulfiram, phenytoin, saquinavir, or tacrolimus because the risk of their side effects may be increased by Omeprazole Delayed-Release Capsules


• Ampicillins, azole antifungals (eg, ketoconazole), clopidogrel, HIV protease inhibitors (eg, atazanavir, nelfinavir), iron, mycophenolate, or tyrosine kinase inhibitors (eg, dasatinib, erlotinib) because their effectiveness may be decreased by Omeprazole Delayed-Release Capsules

This may not be a complete list of all interactions that may occur. Ask your health care provider if Omeprazole Delayed-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Omeprazole Delayed-Release Capsules:

Use Omeprazole Delayed-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Omeprazole Delayed-Release Capsules by mouth at least 1 hour before a meal.


• Swallow Omeprazole Delayed-Release Capsules whole. Do not break, crush, chew, or open Omeprazole Delayed-Release Capsules before swallowing.


• If you have trouble swallowing the capsule, add 1 tablespoon of applesauce to an empty bowl. Open the capsule and empty the pellets onto the applesauce. Mix the pellets with the applesauce and swallow the mixture at once, followed by a glass of cool water. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. Do not chew or crush the pellets. Do not store the mixture for further use.


• You may take antacids while you are taking Omeprazole Delayed-Release Capsules if you are directed to do so by your doctor.


• Continue to take Omeprazole Delayed-Release Capsules even if you feel well. Do not miss any doses.


• If you miss a dose of Omeprazole Delayed-Release Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Omeprazole Delayed-Release Capsules.

Important safety information:

• Omeprazole Delayed-Release Capsules may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Omeprazole Delayed-Release Capsules with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Contact your doctor if you have any symptoms of a bleeding ulcer, such as black, tarry stools or vomit that looks like coffee grounds, or if you experience throat pain, chest pain, severe stomach pain, or trouble swallowing.


• Omeprazole Delayed-Release Capsules may increase the risk of hip, wrist, and spine fractures in patients with weak bones (osteoporosis). The risk may be greater if you use Omeprazole Delayed-Release Capsules in high doses, for longer than a year, or if you are over 50 years old. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. Contact your doctor if you have any questions about this information.


• Low blood magnesium levels have been reported rarely in patients taking PPIs for at least 3 months. In most cases, this effect was seen after a year of treatment. If you will be taking Omeprazole Delayed-Release Capsules for a long time, or if you take certain other medicines (eg, digoxin, diuretics), your doctor may perform lab tests to check for low blood magnesium levels. Seek medical attention right away if you experience symptoms of low blood magnesium levels (eg, dizziness; fast or irregular heartbeat; involuntary muscle movements; jitteriness or tremors; muscle aches, cramps, pain, spasms, or weakness; seizures).


• Check with your doctor to see whether you should take a calcium and vitamin D supplement while you take Omeprazole Delayed-Release Capsules.


• Omeprazole Delayed-Release Capsules may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Omeprazole Delayed-Release Capsules.


• Omeprazole Delayed-Release Capsules should be used with caution in Asian patients; the risk of side effects may be increased in these patients.


• Use Omeprazole Delayed-Release Capsules with caution in the ELDERLY; they may be more sensitive to its effects, especially hip, wrist, and spine fractures.


• Omeprazole Delayed-Release Capsules should be used with extreme caution in CHILDREN younger than 1 year old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Omeprazole Delayed-Release Capsules while you are pregnant. Omeprazole Delayed-Release Capsules are found in breast milk. Do not breast-feed while taking Omeprazole Delayed-Release Capsules.

Possible side effects of Omeprazole Delayed-Release Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; gas; headache; nausea; stomach pain; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bone pain; chest pain; dark urine; fast, slow, or irregular heartbeat; fever, chills, or sore throat; red, swollen, blistered, or peeling skin; severe diarrhea; severe stomach pain or cramps; swelling of the hands, ankles, or feet; unusual bruising or bleeding; unusual tiredness; vision changes; yellowing of the eyes or skin.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Omeprazole side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; fast heartbeat; flushing; increased sweating; severe headache, drowsiness, or nausea; vomiting.

Proper storage of Omeprazole Delayed-Release Capsules:

Store Omeprazole Delayed-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Omeprazole Delayed-Release Capsules out of the reach of children and away from pets.

General information:

• If you have any questions about Omeprazole Delayed-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.


• Omeprazole Delayed-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Omeprazole Delayed-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Omeprazole resources

• Omeprazole Side Effects (in more detail)
• Omeprazole Dosage
• Omeprazole Use in Pregnancy & Breastfeeding
• Drug Images
• Omeprazole Drug Interactions
• Omeprazole Support Group
• 46 Reviews for Omeprazole - Add your own review/rating

Compare Omeprazole with other medications

• Barrett's Esophagus
• Duodenal Ulcer
• Erosive Esophagitis
• GERD
• Helicobacter Pylori Infection
• Indigestion
• Multiple Endocrine Adenomas
• Stomach Ulcer
• Systemic Mastocytosis
• Zollinger-Ellison Syndrome

Fluoxetina DOC

Fluoxetina DOC may be available in the countries listed below.

Ingredient matches for Fluoxetina DOC

Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina DOC in the following countries:

• Italy

International Drug Name Search